Brief: Light AI Announces Initiation Of FDA Pivotal Clinical Trial For Quickscan™ Strep A Software As A Medical Device (Samd)
04/06/2026 12:10
BRIEF-Light AI Announces Initiation Of FDA Pivotal Clinical Trial For Quickscan™ Strep A Software As A Medical Device (Samd) June 4 (Reuters) - Light AI Inc ALGO.NLB:
LIGHT AI ANNOUNCES INITIATION OF FDA PIVOTAL CLINICAL TRIAL FOR QUICKSCAN™ STREP A SOFTWARE AS A MEDICAL DEVICE (SAMD)
Source text: ID:nCNWj4CR4a
Further company coverage: ALGO.NLB
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Clas Ohlson AB
See all newsAdvisory: Alert incorrectly tagged to Clas Ohlson AB is withdrawn
Brief: Light AI Announces Initiation Of FDA Pivotal Clinical Trial For Quickscan™ Strep A Software As A Medical Device (Samd)
Clas Ohlson slumps after Q4 EBIT miss, somewhat disappointing CMD targets
Sweden's Clas Ohlson Q4 sales rise on e-commerce growth
Brief: Clas Ohlson Q4 Oper Profit Up At SEK 180 Mln